Annual CFI
$20.44 M
+$40.93 M+199.80%
31 December 2023
Summary:
Silence Therapeutics annual cash flow from investing activities is currently $20.44 million, with the most recent change of +$40.93 million (+199.80%) on 31 December 2023. During the last 3 years, it has risen by +$8.10 million (+65.62%). SLN annual CFI is now at all-time high.SLN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$39.05 M
-$40.00 M-4197.61%
01 September 2024
Summary:
Silence Therapeutics quarterly cash flow from investing activities is currently -$39.05 million, with the most recent change of -$40.00 million (-4197.61%) on 01 September 2024. Over the past year, it has dropped by -$65.10 million (-249.88%). SLN quarterly CFI is now -249.88% below its all-time high of $26.05 million, reached on 30 September 2023.SLN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$87.48 M
-$65.10 M-290.93%
01 September 2024
Summary:
Silence Therapeutics TTM cash flow from investing activities is currently -$87.48 million, with the most recent change of -$65.10 million (-290.93%) on 01 September 2024. Over the past year, it has dropped by -$87.47 million (-678053.49%). SLN TTM CFI is now -527.90% below its all-time high of $20.44 million, reached on 31 December 2023.SLN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +199.8% | -249.9% | -10000.0% |
| 3 y3 years | +65.6% | -705.3% | -1602.1% |
| 5 y5 years | +417.2% | - | - |
SLN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +199.8% | -249.9% | +21.1% | -527.9% | at low |
| 5 y | 5 years | at high | +199.8% | -249.9% | +21.1% | -527.9% | at low |
| alltime | all time | at high | +199.8% | -249.9% | +21.1% | -527.9% | at low |
Silence Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$39.05 M(-4197.6%) | -$87.48 M(+290.9%) |
| June 2024 | - | $953.00 K(-101.9%) | -$22.38 M(-23.4%) |
| Mar 2024 | - | -$49.51 M(<-9900.0%) | -$29.22 M(-242.9%) |
| Dec 2023 | $20.44 M(-199.8%) | $123.30 K(-99.5%) | $20.44 M(<-9900.0%) |
| Sept 2023 | - | $26.05 M(-542.5%) | -$12.90 K(-100.0%) |
| June 2023 | - | -$5.89 M(-3884.2%) | -$26.11 M(+28.9%) |
| Mar 2023 | - | $155.60 K(-100.8%) | -$20.26 M(-1.1%) |
| Dec 2022 | -$20.48 M(-271.6%) | -$20.33 M(>+9900.0%) | -$20.48 M(-443.6%) |
| Sept 2022 | - | -$42.50 K(+7.1%) | $5.96 M(-52.1%) |
| June 2022 | - | -$39.70 K(-42.0%) | $12.46 M(+4.8%) |
| Mar 2022 | - | -$68.40 K(-101.1%) | $11.89 M(-0.4%) |
| Dec 2021 | $11.94 M(-3.3%) | $6.11 M(-5.3%) | $11.94 M(+104.9%) |
| Sept 2021 | - | $6.45 M(-1158.2%) | $5.82 M(-1028.0%) |
| June 2021 | - | -$609.70 K(+3306.1%) | -$627.60 K(+3406.1%) |
| Mar 2021 | - | -$17.90 K | -$17.90 K |
| Dec 2020 | $12.34 M(-164.4%) | - | - |
| Dec 2019 | -$19.17 M(+197.5%) | - | - |
| Dec 2018 | -$6.44 M(-138.4%) | - | - |
| Dec 2017 | $16.80 M(-365.3%) | - | - |
| Dec 2016 | -$6.33 M(-195.8%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2015 | $6.61 M(-2095.0%) | - | - |
| Dec 2014 | -$331.30 K(-95.8%) | - | - |
| Dec 2013 | -$7.98 M(+3683.8%) | - | - |
| Dec 2012 | -$210.80 K(-46.1%) | - | - |
| Dec 2011 | -$391.30 K(-145.6%) | - | - |
| Dec 2010 | $858.70 K(-406.2%) | - | - |
| Dec 2009 | -$280.40 K(-1268.3%) | - | - |
| Dec 2008 | $24.00 K(0.0%) | - | - |
| Dec 2007 | $24.00 K(-94.0%) | - | - |
| Dec 2006 | $401.90 K(-204.2%) | - | - |
| Dec 2005 | -$385.70 K(+78.3%) | - | - |
| Dec 2004 | -$216.30 K(+207.7%) | - | - |
| Dec 2003 | -$70.30 K(-100.6%) | - | - |
| Dec 2002 | $11.92 M(+447.8%) | - | - |
| Dec 2001 | $2.18 M(-255.1%) | - | - |
| Dec 2000 | -$1.40 M(-86.0%) | - | - |
| Dec 1999 | -$10.01 M(-511.1%) | - | - |
| Dec 1998 | $2.43 M(<-9900.0%) | - | - |
| Dec 1997 | -$11.50 K(-92.4%) | - | - |
| Dec 1996 | -$151.50 K(-125.0%) | - | - |
| Dec 1995 | $606.10 K | - | - |
FAQ
- What is Silence Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Silence Therapeutics?
- What is Silence Therapeutics annual CFI year-on-year change?
- What is Silence Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Silence Therapeutics?
- What is Silence Therapeutics quarterly CFI year-on-year change?
- What is Silence Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Silence Therapeutics?
- What is Silence Therapeutics TTM CFI year-on-year change?
What is Silence Therapeutics annual cash flow from investing activities?
The current annual CFI of SLN is $20.44 M
What is the all time high annual CFI for Silence Therapeutics?
Silence Therapeutics all-time high annual cash flow from investing activities is $20.44 M
What is Silence Therapeutics annual CFI year-on-year change?
Over the past year, SLN annual cash flow from investing activities has changed by +$40.93 M (+199.80%)
What is Silence Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of SLN is -$39.05 M
What is the all time high quarterly CFI for Silence Therapeutics?
Silence Therapeutics all-time high quarterly cash flow from investing activities is $26.05 M
What is Silence Therapeutics quarterly CFI year-on-year change?
Over the past year, SLN quarterly cash flow from investing activities has changed by -$65.10 M (-249.88%)
What is Silence Therapeutics TTM cash flow from investing activities?
The current TTM CFI of SLN is -$87.48 M
What is the all time high TTM CFI for Silence Therapeutics?
Silence Therapeutics all-time high TTM cash flow from investing activities is $20.44 M
What is Silence Therapeutics TTM CFI year-on-year change?
Over the past year, SLN TTM cash flow from investing activities has changed by -$87.47 M (-678053.49%)